ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.

November 9, 2001

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985

Radiotherapy Wing Contractor Dropped

March 27, 1981

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986